Alumis Inc., a late-stage biopharma company, is set to participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York, NY. The company will deliver a presentation on September 9 at 10:30 am ET.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9520303-en) on August 29, 2025, and is solely responsible for the information contained therein.